Rapport Therapeutics Inc. Share Price

NASDAQ: RAPP

Small Cap

$26.30

+0.11

(+0.44%)

as on September 18, 2025 at 1:29 am IST

$₹

Rapport Therapeutics Inc. Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$25.65
Day's Price Range
$27.25
$26.3
2.47%
Downside
3.61%
Upside
52 Week's Low
52 Week's High
$6.43
52-Week Price Range
$42.27
$26.3
75.55%
Downside
60.72%
Upside

Rapport Therapeutics Inc. share price movements today

Previous Close: $26.19
Open: $26.02
Volume: 739.8K
Day's Low - High: $25.65 - $27.25
52 Week Low - High: $6.43 - $42.27

Rapport Therapeutics Inc. Historical Returns

1 Month Return: + 78.1 %
3 Month Return: + 139.18 %
1 Year Return: + 37.77 %
3 Year Return: 0 %
5 Year Return: 0 %

Rapport Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Rapport Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

-2.98

Dividend Yield

0.00%

PE Ratio (TTM)

20.61

Industry PE ratio

P/B Ratio

20.6083

PEG Ratio

Return On Equity TTM

-29.42%

Rapport Therapeutics Inc. Stock Valuation

Track how Rapport Therapeutics Inc. P/E has moved over time to understand its valuation trends.

Rapport Therapeutics Inc. in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Industry (0.00x)

September 17, 2025

Today (20.61x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: 20.61x

Rapport Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rapport Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Rapport Therapeutics Inc.	NA	$1.1B	NA	20.61	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Rapport Therapeutics Inc. Stock including INR - Dollar returns

The Rapport Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Rapport Therapeutics Inc. investment value today

Current value as on today

₹1,42,947

Returns

₹42,947

(+42.95%)

Returns from Rapport Therapeutics Inc. Stock

₹38,348 (+38.35%)

Dollar Returns*

₹4,598 (+4.6%)

Rapport Therapeutics Inc. Stock's Interest Amongst Investors

Search interest for Rapport Therapeutics Inc. Stock has increased by 1300% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:1300% versus previous 30 day period

Rapport Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	0	-	-
Gross Profit	0	0	-	0	0	0	0	0	0	0
Operating Income	-5	-6	-9	-14	-17	-20	-21	-23	-27	-29
EBITDA	-5	-6	-9	-13	-16	-20	-21	-23	-27	-29
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-6	-8	-13	-22	-18	-17	-19	-24	-26
Income Tax Expense	0	0	0	0	-	-	-	-	-	-
Net Income	-6	-6	-8	-13	-22	-18	-17	-19	-24	-26
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-2775.00%	0.00%	0.00%

Rapport Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024
Total Revenue	-	-
Gross Profit	0	0
Operating Income	-36	-83
EBITDA	-34	-77
Interest Expense	-	-
Depreciation	0	0
Income Before Tax	-34	-78
Income Tax Expense	0	-
Net Income	-34	-78
Net Profit Margin	0.00%	0.00%

Rapport Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-6	-8	-13	-22	-18	-17	-19	-24	-26
Operating Cash Flow	-6	-5	-10	-17	-16	-16	-14	-20	-25
Investing Cash Flow	0	0	-78	-41	-107	-53	31	21	22
Financing Cash Flow	0	85	0	63	159	-1	0	0	0
Change in Cash	-6	79	-89	4	35	-70	17	0	-2

Rapport Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024
Net Income	-34	-78
Operating Cash Flow	-27	-64
Investing Cash Flow	-78	-170
Financing Cash Flow	145	221
Change in Cash	39	-13

Insights on Rapport Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, RAPP stock has moved up by 16.9%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 30.3%

About Rapport Therapeutics Inc.

Rapport Therapeutics, Inc. is a clinical-stage biotechnology company engaged in discovering and developing small-molecule precision medicines for patients with neurological or psychiatric disorders. It has made discoveries related to the function of receptor-associated proteins (RAPs) in the brain. Its RAP technology platform enables a differentiated approach to generate precision small molecule product candidates with the potential to overcome many limitations of conventional neurology drug discovery. Its precision neuroscience pipeline includes its lead investigational drug, RAP-219, designed to achieve neuroanatomical specificity through its selective targeting of a RAP expressed in only discrete regions of the brain. It is pursuing RAP-219 as a treatment for refractory focal epilepsy, bipolar mania and diabetic peripheral neuropathic pain. Additional preclinical and late-stage discovery stage programs are also underway, including targeting chronic pain and hearing disorders.

Organisation	Rapport Therapeutics Inc.
Headquarters	1325 Boylston Street, Boston, MA, United States, 02215
CEO	Mr. Abraham N. Ceesay M.B.A.
E-voting on shares	Click here to vote

Key Management of Rapport Therapeutics Inc.

Name	Title
Mr. David Bredt M.D., Ph.D.	Founder & Chief Scientific Officer
Ms. Julie DiCarlo	Head of Communications & Investor Relations
Ms. Kathleen A. Wilkinson	Chief People Officer
Mr. Swamy Yeleswaram Ph.D.	Chief Development Officer
Dr. Arnold R. Gammaitoni Pharm.D.	Senior Vice President of Medical Affairs
Dr. Steven M. Paul M.D.	Founder & Independent Chairman
Mr. Abraham N. Ceesay M.B.A.	CEO, President, Treasurer & Director
Dr. Troy A. Ignelzi	Chief Financial Officer
Ms. Cheryl Gault	Chief Operating Officer
Ms. Karina Chmielewski	Chief Information Officer & Head of Operations

FAQs

What is Rapport Therapeutics Inc. share price today?

Rapport Therapeutics Inc. share price today is $26.3 as on September 18, 2025 at 1:29 am IST at the close of the market. Rapport Therapeutics Inc. share today touched a day high of $27.25 and a low of $25.65.

What is the 52 week high and 52 week low for Rapport Therapeutics Inc. share?

Rapport Therapeutics Inc. share touched a 52 week high of $42.27 on September 8, 2025 and a 52 week low of $6.43 on March 4, 2025. Rapport Therapeutics Inc. stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $26.3,which is 37.78% down from its 52 week high and 309.02% up from its 52 week low.

What is Rapport Therapeutics Inc.'s market capitalisation today?

Rapport Therapeutics Inc. market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Rapport Therapeutics Inc. Stock (RAPP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Rapport Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rapport Therapeutics Inc. Shares that will get you 0.0570 shares as per Rapport Therapeutics Inc. share price of $26.3 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Rapport Therapeutics Inc. Stock (RAPP) from India?

Indian investors can start investing in Rapport Therapeutics Inc. (RAPP) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 4:36 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Rapport Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 4:36 am IST). Based on Rapport Therapeutics Inc. share’s latest price of $26.3 as on September 18, 2025 at 1:29 am IST, you will get 0.3802 shares of Rapport Therapeutics Inc.. Learn more about fractional shares .